Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sader HS et al. – High rates of methicillin–resistant staphylococci and vancomycin–resistant enterococci were observed in US hospitals, but daptomycin remains active against these clinically important Gram–positive organisms with no evidence of potency loss since its approval for clinical use in late 2003.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address